Institution benchmarking
The positions shown in the tables below are based on the Share of an institution's research output overall and in each subject area globally.
Overall
Institution | 2019 | 2022 | 2023 |
---|---|---|---|
CapitalBio Corporation, China | 2297 | 6958 | 6008 |
Biological sciences
Institution | 2019 | 2023 |
---|---|---|
CapitalBio Corporation, China | 2459 | 2942 |
Chemistry
Institution | 2019 | 2022 | 2023 |
---|---|---|---|
CapitalBio Corporation, China | 1347 | 2332 | 2471 |
Health sciences
Institution | 2023 |
---|---|
CapitalBio Corporation, China | 3356 |
Physical sciences
Institution | 2022 |
---|---|
CapitalBio Corporation, China | 2524 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Comprehensive deep-dives and custom high-quality reports
Nature Strategy Reports gives you simple insights into what matters most
The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.